Upacicalcet
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
4
Phase 4
0
Earliest trial started Jun 20, 2017 (NCT03226171)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1c(Cl)cc(S(=O)(=O)O)cc1NC(=O)NC[C@H](N)C(=O)O- Mol. weight
- 351.77 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL6068421 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05836220 | Phase 3 | May 15, 2023 | Launch Therapeutics, Pathalys Pharma |
| NCT05832931 | Phase 3 | Apr 28, 2023 | Launch Therapeutics, Pathalys Pharma |
| NCT03801980 | Phase 3 | Jan 21, 2019 | Sanwa Kagaku Kenkyusho Co., Ltd. |
| NCT03626948 | Phase 3 | Sep 30, 2018 | Sanwa Kagaku Kenkyusho Co., Ltd. |
| NCT03226171 | Phase 2 | Jun 20, 2017 | Sanwa Kagaku Kenkyusho Co., Ltd. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanwa Kagaku Kenkyusho Co., Ltd. | For profit | 3 | 3 | 2 | 2017 |
| Launch Therapeutics | For profit | 2 | 0 | 1 | 2023 |
| Pathalys Pharma | For profit | 2 | 2 | 1 | 2023 |
3 organizations
Page 1 / 1